MCAM and colorectal carcinoma: More recently, melanoma cell adhesion molecule (MCAM)‐positive CAFs have also been shown to promote immune suppressive CRC TME by increasing NF‐κB‐IL34/CCL8 signaling via interleukin‐1 receptor 1 interaction and promoting macrophage infiltration [210].